Research Australia is calling on the Commonwealth Government to use the upcoming Federal Budget to drive the health and investment our country deserves. It’s time for the budget to commit to the critical strategic investments needed for the future health and wealth of our nation.
The rising chronic disease burden, ongoing inequities in access to healthcare and health outcomes, and lack of economic diversification are but a few of the key challenges which threaten fiscal sustainability, productivity and the entrenchment of disadvantage across generations.
In 2025 we developed the National Health and Medical Research Strategy and undertook the Strategic Examination of R&D. In 2026, the Commonwealth Government must act boldly and decisively to reimagine the role of public investment in health and medical research and innovation as a catalyst to deliver long-term and equitable social, economic and productivity dividends. We should not waste any more time!
The first priority is to release all available MRFF funds that are sitting idle while Australia’s health and medical research and innovation sector face growing pressures. This is not new spending; this is about ensuring long-term sustainability and smarter investment across our sector.
By investing in health and medical research, government can improve health outcomes today while building the productive capacity and economic resilience Australia needs for the future”, said Nadia Levin, CEO of Research Australia.
“Since identifying the funds in 2023, we’ve been working with government to ensure these funds are utilised including in investing in our early and mid-career researchers for sustainable impact in our sector and developing a new research active healthcare mission in the MRFF to better support the translation of research”.
You can read Research Australia’s 2026-27 Pre-Budget Submission, which outlines further policy proposals, here.
